FYTTD1 Inhibitors
Inhibitors of FYTTD1 operate through a series of biochemical mechanisms that target signaling pathways and cellular processes to induce a decrease in its functional activity. Compounds such as Rapamycin, PP242, Torin 1, KU 0063794, and AZD8055 are potent inhibitors of the mTOR pathway, a crucial regulator of protein synthesis and cell growth. By blocking mTORC1 and mTORC2, these inhibitors may indirectly suppress the activity of FYTTD1, by potentially affecting the expression or post-translational modifications of proteins that interact with or are regulated by FYTTD1. This reduction in the phosphorylation and activation of these proteins could lead to a diminished functional state of FYTTD1, as it may rely on such post-translational modifications for its activity.
On a similar note, the PI3K/Akt pathway, another significant regulator of cell survival and metabolism, is targeted by compounds like LY 294002, Wortmannin, PF-04691502, GSK 690693, BEZ235, and MK-2206. These inhibitors prevent the activation of Akt, thereby potentially reducing the phosphorylation of downstream targets involved in FYTTD1's functional pathways. Triciribine, a specific Akt inhibitor, also contributes to this effect by directly impeding Akt signaling. The inhibition of these pathways leads to a decrease in the functional activity of FYTTD1 by limiting the phosphorylation and activation of associated proteins, which could be crucial for the proper functioning of FYTTD1. Collectively, these inhibitors leverage the interconnected nature of cellular signaling to reduce FYTTD1 activity without directly affecting its expression levels.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that blocks the function of the mTOR complex, which may indirectly decrease the function of FYTTD1 by reducing overall protein translation, including proteins that could be substrates or regulators of FYTTD1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that impedes the PI3K/Akt/mTOR signaling pathway, potentially diminishing the phosphorylation and activation of substrates relevant to FYTTD1, thereby reducing its functional activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that attenuates the PI3K/Akt/mTOR signaling cascade, indirectly leading to decreased activity of FYTTD1 by limiting the phosphorylation of associated proteins. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
An Akt inhibitor that can suppress Akt signaling, potentially resulting in reduced activity of downstream proteins like FYTTD1 by preventing their phosphorylation and activation. | ||||||
PP242 | 1092351-67-1 | sc-301606A sc-301606 | 1 mg 5 mg | $57.00 $172.00 | 8 | |
A selective inhibitor of mTOR that can inhibit both mTORC1 and mTORC2, possibly leading to diminished FYTTD1 activity through reduced protein synthesis or altered signal transduction. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $245.00 | 7 | |
A potent mTOR inhibitor that could lead to a decrease in FYTTD1 function by inhibiting the mTOR pathway, which is necessary for protein synthesis and other cellular processes that FYTTD1 may be involved in. | ||||||
KU 0063794 | 938440-64-3 | sc-361219 | 10 mg | $209.00 | ||
A selective mTOR inhibitor that suppresses both mTORC1 and mTORC2, potentially leading to reduced FYTTD1 function through decreased signaling and protein synthesis. | ||||||
GSK 690693 | 937174-76-0 | sc-363280 sc-363280A | 10 mg 50 mg | $255.00 $1071.00 | 4 | |
An Akt inhibitor that may diminish FYTTD1 function by reducing the downstream phosphorylation of proteins in pathways where FYTTD1 is involved. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $211.00 | 8 | |
A dual PI3K/mTOR inhibitor that could indirectly diminish FYTTD1 activity by inhibiting pathways critical for its functional processes. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
An allosteric Akt inhibitor that might decrease FYTTD1 function by preventing the activation of downstream proteins that interact with or regulate FYTTD1. | ||||||